Single bisphosphonate infusion does not speed up fracture healing in high tibial osteotomy .
Questo studio è stato identificato come potenzialmente ad alto impatto.
La metrica High Impact di OE, guidata dall'AI, stima l'influenza che un articolo potrebbe avere integrando i segnali della rivista in cui è stato pubblicato e il contenuto scientifico dell'articolo stesso.
Sviluppato utilizzando un'elaborazione del linguaggio naturale all'avanguardia, il modello High Impact di OE prevede in modo più accurato la futura performance citazionale di uno studio rispetto al solo fattore di impatto della rivista.
Ciò consente di riconoscere prima le ricerche clinicamente significative e aiuta i lettori a concentrarsi sugli articoli che hanno maggiori probabilità di influenzare la pratica futura.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(11):170 Acta Orthop. 2011 Aug;82(4):465-70. Epub 2011 Jun 2146 patients with knee osteoarthritis undergoing high tibial osteotomies were randomized 4 weeks postoperatively to receive a single bisphosphonate infusion of zoledronic acid or a sodium chloride placebo. The primary outcome was reduction in healing time. Other outcomes included hip knee ankle (HKA) angle and patient-relevant outcome measures (Knee injury and osteoarthritis outcomes score (KOOS)). Results indicated that a single bisphosphonate infusion intervention does not accelerate healing in high tibial osteotomies.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Sì = 1
Incerto = 0,5
Non rilevante = 0
No = 0
La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.
3/4
Randomization
4/4
Outcome Measurements
4/4
Inclusion / Exclusion
4/4
Therapy Description
4/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.
Perché questo studio era necessario ora?
Strength of a healing fracture has been known to increase with the use of anti-catabolic drugs, such as bisphosphonates. A human pilot study examined high tibial osteotomies in knee osteoarthritis, which indicated healing time was shortened with the use of bisphosphonates. The current study examines the effect of a bisphosphonate (zoledronic acid) infusion on reducing healing time after high tibial osteotomies.
Qual era la domanda di ricerca principale?
What are the outcomes in rate of fracture healing, hip-knee-ankle (HKA) angle, and patient-relevant outcome measures when a single bisphosphonate (zoledronic acid) infusion is intravenously administered, compared to a sodium chloride placebo in patients with knee osteoarthritis after undergoing a high tibial osteotomy?
- All osteotomies healed in both the zoledronic acid (intervention) and sodium chloride (control) groups.
- No difference was seen in the rate of healing between the intervention and control group. Zoledronic group: 77 days (95% CI: 75-80); Sodium chloride group: 77 days (95%CI: 74-81). However, pin fixation of the external frame increased with the intervention of a single zoledronic acid infusion.
- The DEXA analysis indicated similar outcomes in bone mineral density and bone mineral content between the two groups.
- Both groups showed an improvement in KOOS scores. Small but non-statistically significant differences were seen between the groups.
- For the hip, knee, ankle (HKA) angles, no change was seen between the two groups. The zoledronic group had a mean change of 0.3 (SD 3.3) degrees compared to -1.0 (SD 3.3) degrees in the control group (p=0.2)
- 13/25 patients from the zoledronic group reported muscle pain and influenza-like symptoms compared to 2/21 patients from the placebo group (RR=5, CI: 1.3-20; p=0.004).
- According to the radiographic results, both the intervention and control group retained correction when examined at the 1.5-year follow-up.
Che cosa devo ricordare di più?
The single zoledronic acid (bisphosphonate) infusion intervention did not accelerate healing in high tibial osteotomies when compared to the sodium chloride placebo. However, there was an increase in pin fixation of the external frame in the zoledronic acid group.
Come influenzerà l'assistenza ai miei pazienti?
The use of a single dose of zoledronic acid after undergoing a knee osteotomy does not appear to provide patients with an increased rate of fracture healing. Further examination is required to identify if single dose zoledronic acid treatment provides improved healing rates or superior bone mineral density for different orthopaedic procedures.
DISCLAIMER
Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.
0 di 4 articoli mensili GRATUITI sbloccati
